VRCC To Participate In Clinical Trial Evaluating The Efficacy Of A New Drug To Treat Dogs With Inoperable Grade 2 & 3 Mast Cell Tumours

VRCC is participating in a ‘Clinical Trial’ evaluating the efficacy of a New Drug to treat Dogs with inoperable Grade 2 & 3 Mast Cell Tumours VRCC offers all the most modern treatments for Dogs with Mast Cell Tumours but this ‘Trial’ treatment is now available at VRCC for Dogs where current treatment may not be appropriate or where clients do not or are unable to pursue the conventional route. For full details contact: Beatriz Balana Tapia or Dr Susan North at: VRCC Veterinary Referrals No1 Bramston Way Southfields. Laindon. Essex. SS15 6TP Te: 01268 564664

More from

• NEF calls for unsung equestrians to be honoured
• Novel splint demonstrates reduction in casting complications in dogs in preliminary study
• Willows at the forefront of TKR care across UK and Europe
• New Leadon Vale website highlights stem cell expertise
• Somerset's Cave Veterinary Specialists invests £1.2m in class-leading MRI scanner